Physician profile
Ehsan Abdeshahian
NPI 1871844720
$12,221.56
in general payments reported to CMS, 2019-2025
38 companies · $1,541 in 2025
The $1,541 reported for 2025 was more than what 91% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,264 · 2020: $1,194 · 2021: $1,112 · 2022: $375 · 2023: $1,189 · 2024: $2,548 · 2025: $1,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,271 · Travel and Lodging: $5.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,271.31 |
| Travel and Lodging | $5.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $4,543.17 | 2019-2024 | Senza |
| Boston Scientific Corporation | $1,391.78 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Spaceoar Vue System - 10ml |
| Abbott Laboratories | $1,174.62 | 2021-2025 | Proclaim, Eterna, Octrode |
| Medtronic, INC. | $712.40 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Zyla Life Sciences, INC. | $685.39 | 2019-2020 | |
| Indivior INC. | $523.14 | 2019-2025 | Sublocade |
| Merz North America, INC. | $492.99 | 2019-2025 | |
| Vertos Medical, INC. | $380.91 | 2022-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $316.12 | 2019-2025 | Xtampza, Belbuca |
| Scilex Pharmaceuticals INC. | $244.84 | 2019-2025 | Ztlido |
| Medtronic USA, INC. | $217.58 | 2019-2020 | |
| Stimwave Technologies Incorporated | $190.09 | 2020 | |
| Saluda Medical Americas, INC. | $130.88 | 2025 | Evoke |
| Abbvie INC. | $129.15 | 2025 | |
| Mdd US Operations, LLC | $105.30 | 2019-2020 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ehsan Abdeshahian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.